|
1
|
Human infection with a novel avian-origin influenza A (H7N9) virus.
|
N Engl J Med
|
2013
|
24.88
|
|
2
|
Nosocomial transmission of human granulocytic anaplasmosis in China.
|
JAMA
|
2008
|
5.01
|
|
3
|
Probable limited person-to-person transmission of highly pathogenic avian influenza A (H5N1) virus in China.
|
Lancet
|
2008
|
4.17
|
|
4
|
An emerging recombinant human enterovirus 71 responsible for the 2008 outbreak of hand foot and mouth disease in Fuyang city of China.
|
Virol J
|
2010
|
3.90
|
|
5
|
Biological features of novel avian influenza A (H7N9) virus.
|
Nature
|
2013
|
3.24
|
|
6
|
Person-to-person transmission of severe fever with thrombocytopenia syndrome bunyavirus through blood contact.
|
Clin Infect Dis
|
2011
|
2.59
|
|
7
|
Severe fever with thrombocytopenia syndrome virus among domesticated animals, China.
|
Emerg Infect Dis
|
2013
|
2.35
|
|
8
|
Early diagnosis of novel SFTS bunyavirus infection by quantitative real-time RT-PCR assay.
|
J Clin Virol
|
2011
|
2.19
|
|
9
|
Lethal avian influenza A (H5N1) infection in a pregnant woman in Anhui Province, China.
|
N Engl J Med
|
2006
|
1.99
|
|
10
|
Hantavirus-like particles generated in CHO cells induce specific immune responses in C57BL/6 mice.
|
Vaccine
|
2010
|
1.92
|
|
11
|
Indications that live poultry markets are a major source of human H5N1 influenza virus infection in China.
|
J Virol
|
2011
|
1.85
|
|
12
|
The first confirmed human case of avian influenza A (H5N1) in Mainland China.
|
Lancet
|
2006
|
1.79
|
|
13
|
Pathogenesis of emerging severe fever with thrombocytopenia syndrome virus in C57/BL6 mouse model.
|
Proc Natl Acad Sci U S A
|
2012
|
1.71
|
|
14
|
Outbreak of acute respiratory disease in China caused by B2 species of adenovirus type 11.
|
J Clin Microbiol
|
2008
|
1.67
|
|
15
|
Laboratory diagnosis of four recent sporadic cases of community-acquired SARS, Guangdong Province, China.
|
Emerg Infect Dis
|
2004
|
1.65
|
|
16
|
Host cytokine storm is associated with disease severity of severe fever with thrombocytopenia syndrome.
|
J Infect Dis
|
2012
|
1.62
|
|
17
|
The seroprevalence of pandemic influenza H1N1 (2009) virus in China.
|
PLoS One
|
2011
|
1.54
|
|
18
|
Novel bunyavirus in domestic and captive farmed animals, Minnesota, USA.
|
Emerg Infect Dis
|
2013
|
1.53
|
|
19
|
Genomic analyses of recombinant adenovirus type 11a in China.
|
J Clin Microbiol
|
2009
|
1.41
|
|
20
|
Generation, characterization and epitope mapping of two neutralizing and protective human recombinant antibodies against influenza A H5N1 viruses.
|
PLoS One
|
2009
|
1.33
|
|
21
|
Suppression of the interferon and NF-κB responses by severe fever with thrombocytopenia syndrome virus.
|
J Virol
|
2012
|
1.17
|
|
22
|
Critical epitopes in the nucleocapsid protein of SFTS virus recognized by a panel of SFTS patients derived human monoclonal antibodies.
|
PLoS One
|
2012
|
1.07
|
|
23
|
A systematic molecular pathology study of a laboratory confirmed H5N1 human case.
|
PLoS One
|
2010
|
1.07
|
|
24
|
Genetic analysis of chikungunya viruses imported to mainland China in 2008.
|
Virol J
|
2010
|
1.05
|
|
25
|
Generation of recombinant vaccinia viruses expressing Puumala virus proteins and use in isolating cytotoxic T cells specific for Puumala virus.
|
Virus Res
|
2002
|
1.01
|
|
26
|
Structure of severe fever with thrombocytopenia syndrome virus nucleocapsid protein in complex with suramin reveals therapeutic potential.
|
J Virol
|
2013
|
0.99
|
|
27
|
Avian influenza A(H5N1) viruses can directly infect and replicate in human gut tissues.
|
J Infect Dis
|
2010
|
0.96
|
|
28
|
Generation of an HFRS patient-derived neutralizing recombinant antibody to Hantaan virus G1 protein and definition of the neutralizing domain.
|
J Med Virol
|
2003
|
0.94
|
|
29
|
Evasion of antiviral immunity through sequestering of TBK1/IKKε/IRF3 into viral inclusion bodies.
|
J Virol
|
2013
|
0.92
|
|
30
|
Hepatitis C virus envelope glycoproteins complementation patterns and the role of the ecto- and transmembrane domains.
|
Biochem Biophys Res Commun
|
2009
|
0.92
|
|
31
|
Suppression of type I and type III IFN signalling by NSs protein of severe fever with thrombocytopenia syndrome virus through inhibition of STAT1 phosphorylation and activation.
|
J Gen Virol
|
2015
|
0.84
|
|
32
|
Vaccination with dengue virus-like particles induces humoral and cellular immune responses in mice.
|
Virol J
|
2011
|
0.81
|
|
33
|
Interactions of SARS coronavirus nucleocapsid protein with the host cell proteasome subunit p42.
|
Virol J
|
2010
|
0.80
|
|
34
|
Maternally derived recombinant human anti-hantavirus monoclonal antibodies are transferred to mouse offspring during lactation and neutralize virus in vitro.
|
J Virol
|
2006
|
0.80
|
|
35
|
Identification and immunogenicity of two new HLA-A*0201-restricted CD8+ T-cell epitopes on dengue NS1 protein.
|
Int Immunol
|
2012
|
0.79
|
|
36
|
Efficient neutralizing activity of cocktailed recombinant human antibodies against hepatitis A virus infection in vitro and in vivo.
|
J Med Virol
|
2008
|
0.78
|
|
37
|
Mechanisms of selective head cooling for resuscitating damaged neurons during post-ischemic reperfusion.
|
Chin Med J (Engl)
|
2002
|
0.78
|
|
38
|
An ocular drug delivery system containing zinc diethyldithiocarbamate and HPbetaCD inclusion complex--corneal permeability, anti-cataract effects and mechanism studies.
|
J Pharm Pharmacol
|
2004
|
0.78
|
|
39
|
Zika Virus in a Traveler Returning to China from Caracas, Venezuela, February 2016.
|
Emerg Infect Dis
|
2016
|
0.78
|
|
40
|
Secretory expression and purification of recombinant Escherichia coli heat-labile enterotoxin B subunit and its applications on intranasal vaccination of hantavirus.
|
Mol Biotechnol
|
2008
|
0.77
|
|
41
|
[Molecular cloning,nucleotides sequence and transient expression of S and M genome segment of hantavirus strain 84Fli].
|
Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi
|
2002
|
0.77
|
|
42
|
Bioavailability and anticataract effects of a topical ocular drug delivery system containing disulfiram and hydroxypropyl-beta-cyclodextrin on selenite-treated rats.
|
Curr Eye Res
|
2004
|
0.76
|
|
43
|
Fusion with extracellular domain of cytotoxic T-lymphocyte-associated-antigen 4 leads to enhancement of immunogenicity of Hantaan virus DNA vaccines in C57BL/6 mice.
|
Virol J
|
2011
|
0.76
|
|
44
|
Rapid, specific detection of alphaviruses from tissue cultures using a replicon-defective reporter gene assay.
|
PLoS One
|
2012
|
0.76
|
|
45
|
Tracking hantavirus nucleocapsid protein using intracellular antibodies.
|
Virol J
|
2010
|
0.76
|
|
46
|
Oral immunization with recombinant enterovirus 71 VP1 formulated with chitosan protects mice against lethal challenge.
|
Virol J
|
2014
|
0.75
|
|
47
|
[Zika Virus and Zika Viral Disease].
|
Bing Du Xue Bao
|
2016
|
0.75
|
|
48
|
[Purification and Preliminary Research on the Immunogenicity of Inactivated Severe Fever with Thrombocytopenia Syndrome Bunyavirus].
|
Bing Du Xue Bao
|
2015
|
0.75
|
|
49
|
[New Method for Stable Expression of SFTS Virus-like Particles in CHO-K1 Cells].
|
Bing Du Xue Bao
|
2015
|
0.75
|
|
50
|
[Infection of the Severe Fever with Thrombocytopenia Syndrome Virus in Balb/C Mice and Hamsters].
|
Bing Du Xue Bao
|
2015
|
0.75
|
|
51
|
[Epidemiological characteristics of Zika virus disease].
|
Zhonghua Liu Xing Bing Xue Za Zhi
|
2016
|
0.75
|
|
52
|
Generation and characterization of neutralizing human recombinant antibodies against antigenic site II of rabies virus glycoprotein.
|
Appl Microbiol Biotechnol
|
2012
|
0.75
|
|
53
|
[Preparation and functional analysis of the monoclonal antibodies against severe fever with thrombocytopenia syndrome bunyavirus structural proteins].
|
Bing Du Xue Bao
|
2015
|
0.75
|
|
54
|
New heavy-fermion antiferromagnet UPd2Cd20.
|
J Phys Condens Matter
|
2016
|
0.75
|